Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Broadly neutralizing monoclonal antibodies protect against infection with HIV-1 in animal models, suggesting that a vaccine that elicits these antibodies would be protective in humans. However, it has not yet been possible to induce adequate serological responses by vaccination. Here, to activate B...
Main Author: | Irvine, Darrell J. |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/1721.1/124756 |
Similar Items
-
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env
by: Escolano, Amelia, et al.
Published: (2023) -
Expanding the stoichiometric window for metal cross-linked gel assembly using competition
by: Cazzell, Seth Allen, et al.
Published: (2020) -
In vitro evolution of enhanced RNA replicons for immunotherapy
by: Li, Yingzhong, et al.
Published: (2020) -
Atomic structure of the open SARS-CoV-2 E viroporin
by: Medeiros-Silva, João, et al.
Published: (2024) -
Biosynthesis of the nitrogenase active-site cofactor precursor NifB-co in Saccharomyces cerevisiae
by: Saaem, Ishtiaq Ali, et al.
Published: (2020)